Effectiveness of neurofeedback training as a treatment for opioid-dependent patients

Clinical EEG and Neuroscience

Volumn 41, Issue 3, 2010, Pages 170-177

  Arani, Fateme Dehghani ^a   Rostami, Reza ^a   Nostratabadi, Masoud ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Biofeedback; Craving; Neurofeedback training; Opioid dependant; Psychopathological symptoms; Quantitative electroencephalography

Indexed keywords

ADULT; AGGRESSION; ARTICLE; CHECKLIST; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEEDBACK SYSTEM; HUMAN; MALE; MULTIVARIATE ANALYSIS OF COVARIANCE; NEUROFEEDBACK TRAINING; NEUROPSYCHOLOGY; OBSESSION; OPIATE ADDICTION; PRIORITY JOURNAL; PSYCHOSIS; QUESTIONNAIRE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME; ANALYSIS OF VARIANCE; ELECTROENCEPHALOGRAPHY; MIDDLE AGED; OPIOID-RELATED DISORDERS; PROCEDURES; PSYCHOLOGY; PSYCHOPHYSIOLOGY; REGRESSION ANALYSIS;

ADULT; ANALYSIS OF VARIANCE; BIOFEEDBACK, PSYCHOLOGY; ELECTROENCEPHALOGRAPHY; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; QUESTIONNAIRES; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 77955634116     PISSN: 15500594     EISSN: None     Source Type: Journal    
DOI: 10.1177/155005941004100313     Document Type: Article

References (61)

1. Hubbard JR, Martin PR. Substance Abuse in the Mentally and Physically Disabled. New York: Marcel Dekker; 2001.
2. Kaufman MJ. Brain Imaging in Substance Abuse. Totowa, New Jersey: Humana Press; 2000.
3. Lawrence JT. Neurofeedback and your brain: a beginner's manual. Faculty, New York Medical Center & Brain Research Lab Manual; 2002: 15-20.
4. Monastra VJ, Lynn S, Linden M, Lubar JF, Gruzelier J, LaVaque TJ. Electroencephalographic biofeedback in the treatment of attention-deficit/ hyperactivity disorder. Applied Psychophysiology and Biofeedback 2005; 30 (2): 94-114.
5. Sterman MB. Physiological origins and functional correlates of EEG rhythmic activities: implications for self-regulation. Biofeedback and Self-Regulation 1996; 21 (1): 349.
6. Demos JN. Getting Started with Neurofeedback. New York: W. W. Norton & Company; 2005: 241-278.
7. LaVaque TJ. Neurofeedback, neurotherapy, and QEEG. In: Moss D, McGrady A, Davies A, Wickramasekera I, (eds). Handbook of Mind Body Medicine for Primary Care. Thousand Oaks CA: Sage; 2003: 123-135.
8. Rossiter T. The effectiveness of neurofeedback and stimulant drugs in treating AD/HD: part I. review of methodological issues. Applied Psychophysiology and Biofeedback 2004; 29 (2): 95-112. (Pubitemid 38981515)
9. Fuchs T, Birbaumer N, Lutzenberger W, Gruzelier JH, Kaiser J. Neurofeedback treatment for attention deficit/hyperactivity disorder in children: a comparison with methylphenidate. Applied Psychophysiology and Biofeedback 2003; 28 (1): 1-12.
10. Kotchoubey B, Strehl U, Uhlmann C, Holzapfel S, Konig M, Frascher W, et al. Modification of slow cortical potentials in patients with refractory epilepsy: a controlled outcome study. Epilepsies 2001; 42 (3): 406-416.
11. Putman JA. EEG biofeedback on a female stroke patient with depression: a case study. Journal of Neurotherapy 2001; 5 (3): 27-38.
12. Hammond DC. Neurofeedback with anxiety and affective disorders. Child Adolescent Psychiatric Clinics of North America 2005; 14: 105-123.
13. Vanathy S, Sharma PSVN, Kumar KB. The efficacy of alpha and theta neurofeedback training in treatment of generalized anxiety disorder. Indian Journal of Clinical Psychology 1998; 25 (2): 136-143.
14. Muller HH, Donaldson CCS, Nelson DV, Layman M. Treatment of fibromyalgia incorporating EEG-driven stimulation: a clinical study. Journal of Clinical Psychology 2001; 57 (7): 933-925.
15. Hammond DC. QEEG-guided neurofeedback in the treatment of obsessive compulsive disorder. Journal of Neurotherapy 2003; 7 (2): 25-52.
16. Wilson VE, Peper E, Moss D. Professional issue "the mind room" in Italian soccer training: the use of biofeedback and neurofeedback for optimum performance. Biofeedback 2006; 34: 79-810.
17. Hanslmayr S, Sauseng P, Doppelmayr M, Schabus M, Klimesch W. Increasing individual upper alpha power by neurofeedback improves cognitive performance in human subjects. Applied Psychophysiology and Biofeedback 2005; 30(1): 1-10. (Pubitemid 40767790)
18. Egner T, Gruzelier J. EEG Biofeedback of low beta band components: frequency-specific effects on variables of attention and event-related brain potentials. Clinical Neurophysiology 2005; 115: 131-139. (Pubitemid 38045606)
19. Vernon D, Egner T, Nick C, et al. The effect of training distinct neurofeedback protocols on aspects of cognitive performance. Journal of Psychophysiology 2003; 47 (1): 75-85. (Pubitemid 36113260)
20. Kalechstein A, Gorp WG. Neuropsychology and Substance Use. London: Psychology Press; 2007.
21. Galanter M, Kleber HD. The American Psychiatric Publishing Textbook of Substance Abuse Treatment. New York: American Psychiatric Publishing Incorporated, Fourth Edition, 2008.
22. Keane H. What Is Wrong with Addiction? Melbourne: Melbourne University Press; 2002.
23. Sokhadze TM, Cannon RL, Trudeau DL. EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. Applied Psychophysiology and Biofeedback 2008; 33(1): 1-28.
24. Scott WC, Kaiser D, Othmer S, Sideroff SI. Effects of an EEG biofeedback protocol on a mixed substance abusing population. The American Journal of Drug and Alcohol Abuse 2005; 31: 455469.
25. Egorov AY, Tikhomirav TV. Profiles of brain functional asymmetry in patients with alcoholism and drug addiction. Biochemical Physiology 2004; 40: 557-562.
26. Nader MA, Czoty PA. Brain imaging in nonhuman primates: insights into drug addiction. Behavioral Brain Research 2005; 148: 107-117.
27. Weiss F, Koob GF. Drug addiction: functional neurotoxicity of the brain reward systems. Neurotoxicity Research 200; 3: 145-156.
28. Frederick JA, Timmermann DL, Russell HL, Lubar JF. EEG coherence effects of audio-visual stimulation (AVS) at dominant alpha frequency. Journal of Neurotherapy 2005; 8: (4): 25-42.
29. Kaiser DA, Othmer S, Scott B. Effect of neurofeedback on chemical dependency treatment. Neurofeedback Self-Regulation 1999; 20 (3): 304-305.
30. Saxby E, Peniston EG. Alpha-theta brainwave neurofeedback training: an effective treatment for male and female alcoholics with depressive symptoms. Journal of Clinical Psychology 1995; 51 (5): 685-693.
31. Peniston EG, Kulkosky PJ. Alpha-theta brainwave training and beta-endorphin levels in alcoholics. Clinical and Experimental Research 1989; 13: 271-279.
32. Kelley MJ. Native Americans, neurofeedback, and substance abuse theory: three year outcome of alpha/theta neurofeedback training in the treatment of problem drinking among Dine' (Navajo) people. Journal of Neurotherapy 1997; 2(3): 24-60.
33. Fahrion SL, Walters ED, Coyne L, Allen T. Alteration in EEG amplitude, personality factors and brain electrical mapping after alpha-theta training: a controlled case study of an alcoholic recovery. Clinical and Experimental Research 1992; 16 (3): 547-552.
34. Passini FT, Watson CG, Dehnel L, Herder J, Watkins B. Alpha wave biofeedback training therapy in alcoholics. Journal of Clinical Psychology 1977; 33: 292-299.
35. Goldberg RJ, Greenwood JC, Taintor Z. Alpha conditioning as an adjust treatment for drug dependence. International Journal of Addiction 1976; 11: 1085-1089. (Pubitemid 8090957)
36. Bodenhamer-Davis E, Beus M. Neurotherapy for the treatment of alcohol and drug abuse: results of a two year study. Paper presented at the meeting of the Society of Study of Neuronal Regulation, Scottsdale Arizona; April, 1995.
37. Raymond J, Varney C, Parkinson LA, Gruzelier JH. The effect of alpha/theta neurofeedback on personality and mood. Cognitive Brain Research 2005; 23: 287-292.
38. Derogatils R, Leary P. Confirmation of the dimensional structure of the SCL-90: A study in construct validation. Journal of Clinical Psychology 1977; 33: 981-989.
39. Tiffany ST, Singleton E, Haertzen CA, Henningfield JE. The development of a cocaine craving questionnaire. Drug and Alcohol Dependence 1993; 34, 19-28.
40. Schmitz N, Hartkamp N, Kiuse J, Franke GH, Reister G, Tress W. The Symptom Check-List-90-R (SCL-90-R): a German validation study. Quality of Life Research 2004; 9 (2): 185-193.
41. Derogatis LR. SCL-90-R: assessing behavioral health outcomes in outpatient programs: reliability and validity of the BASIS-32. Journal of Behavioral Health Services and Research 1994; 26: 5-17.
42. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale: preliminary report. Psychopharmacology Bulletin 1973; 9: 13-26.
43. Sayette M, Shiftman S, Tiffany S, Niaura R, Martin C, Shadel W. The measurement of drug craving. Addiction 2000; 95 (2): 189-210.
44. Heinz AJ, Epstein DH, Schroeder JR, Singleton EG, Heishman SJ, Preston KL. Heroin and cocaine craving and use during treatment: measurement validation and potential relationships. Journal of Substance Abuse Treatment 2006; 31: 355-364.
45. Curran HV, Kleckham J, Beam J, Strang J, Wanigaratne S. Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study. Psychopharmacology 2001; 154: 153-160. (Pubitemid 32186500)
46. Donaldson M, Mueller H, Donaldson S, Sello G. QEEG patterns, psychological status and pain reports of fibromyalgia sufferers. Journal of Clinical Psychology 2003; 57 (7): 933-952.
47. Gunkelman JD, Johnstone J. Neurofeedback and the brain. Journal of Adult Development 2005; 12: 2-3.
48. Merkel RL, Cox DJ, Kovatchev B, Kovatchev J, Seward R, Hill R, Reeve R. The EEG consistency index as a measure of AD/HD and responsiveness to medication. Applied Psychophysiology and Biofeedback 2001; 25 (3): 133-142.
49. Hughes J, John ER. Conventional and quantitative electroencephalography in psychiatry. Journal of Neuropsychiatry and Clinical Neuroscience 1999; 11 (2): 190-208.
50. Franken IHA. Drag craving and addiction: integrating psychological and psychopharmacological approaches. Progress Neuro-Pharmacology Biological Psychiatry 2003; 27: 563-579.
51. Stormark KM, Laberg JC, Nordby H, Hugdahl K. Alcoholics' selective attention to alcohol stimuli: automated processing? Journal of Studies on Alcohol 2000; 61: 18-23.
52. Alper KR, Prichep LS, Kowalik S, Rosenthal MS, Roy John E. Persistent QEEG abnormality in Crack Cocaine users at 6 months of drug abstinence. Neuropsychopharmacology 1998; 19: 1-9. (Pubitemid 28255208)
53. Fingelkurts AA, Fingelkurts AA, Kivisaari R, Autti T, Borisov S, Puuskari V, et al. Reorganization of the composition of brain oscillations and their temporal characteristics in opioid dependent patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2006; 30: 1453-1465.
54. Finkelberg A, Sokhadze E, Lopatin A, Shubina O, Kokorina N, Skok A, et al. The application of alpha-theta EEG biofeedback training for psychological improvement in the process of rehabilitation of the patients with pathological addictions. Biofeedback and Self-Regulation 1996; 21: 364.
55. Cowan JD. Alpha-theta brain wave biofeedback: the many possible theoretical reasons for its success. Mega Brain Report: The Journal of Mind Technology 1994; 2 (3): 29-35.
56. Ochs L. EEG treatment of addictions. Biofeedback: News Magazine of the Association for Applied Psychophysiology and Biofeedback 1992; 20 (1): 8-16.
57. Blum K. Reward deficiency syndrome: electro-physiological and biogenetic evidence. Paper presented at the annual meeting of the Society for the Study of Neuronal Regulation, Scottsdale Arizona; April, 1995.
58. Praag H, Kempermann G, Gage FH. Neural consequences of environmental enrichment Nature Reviews Neuroscience 2000; 1: 191-198.
59. Mohammed AH, Zhu SW, Darmopil S, Hjerling-Leffler J, Ernfors P, Winblad B, Diamond MC, Eriksson PS, Bogdanovic N. Environmental enrichment and the brain. Brain Research 2002; 138: 109-133.
60. Rosenzweig MR. Effects of differential experience on the brain and behavior. Developmental Neuropsychology 2003; 24 (2-3): 523-540. (Pubitemid 37370458)
61. Schindler AF, Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends in Neuroscience 2000; 23 (12): 639-645.